3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
66
Lymphoma, Large B-Cell, Diffuse
48
Lymphoma
34
Burkitt Lymphoma
28
Lymphoma, Follicular
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Neoplasms
14
Lymphoma, Non-Hodgkin
14
Lymphoma, B-Cell
12
Lymphoma, T-Cell, Peripheral
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Hodgkin Disease
9
Lymphoma, B-Cell, Marginal Zone
8
Leukemia
7
Recurrence
6
Prostatic Neoplasms, Castration-Resistant
6
Multiple Myeloma
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Neoplasm Metastasis
5
Leukemia, Biphenotypic, Acute
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Lymphoproliferative Disorders
4
Lymphoma, T-Cell
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large-Cell, Anaplastic
4
Immunoblastic Lymphadenopathy
4
Ovarian Neoplasms
3
Myasthenia Gravis
3
Metastatic Castration-resistant Prostate Cancer
3
Melanoma
3
Interventions
Specimen Handling
7
Biopsy
6
Cyclophosphamide
5
ruxolitinib
4
Mycophenolic Acid
4
Busulfan
4
fludarabine phosphate
3
fludarabine
3
Whole-Body Irradiation
3
Tacrolimus
3
Melphalan
3
Injections
3
Decitabine
3
Cyclosporine
3
Azacitidine
3
venetoclax
2
decitabine and cedazuridine drug combination
2
Sirolimus
2
Methotrexate
2
Granulocyte Colony-Stimulating Factor
2
veliparib
1
tocilizumab
1
tagraxofusp
1
posaconazole
1
peginterferon alfa-2b
1
onvansertib
1
merphos
1
iadademstat
1
gilteritinib
1
fedratinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic-Myeloproliferative Diseases
×
Prednisone
×
1 year
×
Clear all
No trials found.